K991083

Substantially Equivalent

RLP CHOLESTEROL IMMUNOSEPARATION ASSAY

Applicant: Otsuka Pharmaceutical Co., Ltd.
Product code: CHH
Advisory panel: Clinical Chemistry
Date received: 1999-03-31
Decision date: 1999-08-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rockville, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.